Hartree Partners, LP 13D and 13G filings for IBERE PHARMACEUTICALS UNIT 1 C:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-08 2:09 pm Sale |
2022-12-31 | 13G | IBERE PHARMACEUTICALS UNIT 1 C IBERU |
Hartree Partners, LP | 0 0.000% |
-1,285,000 (Position Closed) |
Filing |
| 2021-09-27 2:36 pm Purchase |
2021-02-26 | 13G | IBERE PHARMACEUTICALS UNIT 1 C IBERU |
Hartree Partners, LP | 1,285,000 9.300% |
1,285,000 (New Position) |
Filing |